BackBiotech Acquisition Overview

Biotech Acquisition Cost of Revenue

Cost of Revenue analysis for BIOT.

Quarterly Cost of Revenue

$246572.00
60.85% YoY

As of Sep 30, 2022

Annual Cost of Revenue (TTM)

$4.98M
355.42% YoY

Trailing 12 months ending Sep 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)